Medicine and Dentistry
Ovarian Reserve
100%
Antral Follicle
84%
Recurrent Miscarriage
52%
Oocyte Donation
49%
Oocyte
43%
Oral Contraceptive Agent
42%
Childbirth
39%
Birth Rate
36%
Counseling
33%
Lifespan
33%
Disease
29%
Assisted Reproductive Technology
29%
Ovary Function
28%
In Vitro Fertilisation
27%
Immunoglobulin
26%
Recurrent Pregnancy Loss
25%
Oral Contraception
25%
Primary Ovarian Insufficiency
24%
Fertility Preservation
24%
Randomized Controlled Trial
23%
Menstrual Cycle
22%
Consultation
22%
Muellerian Inhibiting Factor
22%
Embryo Transfer
22%
Childhood Cancer
22%
Reproductive Medicine
22%
Ovarian Hyperstimulation Syndrome
22%
Radiation Therapy
22%
Placebo
21%
Intracytoplasmic Sperm Injection
19%
Conception
19%
Hormonal Contraception
19%
Ovarian Tissue Cryopreservation
17%
Cohort Analysis
17%
Maternal Age
17%
First Trimester Pregnancy
16%
Low Birth Weight
16%
Cryopreservation
16%
Diagnosis
16%
Hormone Determination
16%
Prospective Cohort Study
15%
Ovary Insufficiency
14%
Spontaneous Abortion
14%
Autotransplantation
13%
Low Drug Dose
12%
Ovarian Follicle
12%
Population
12%
Immunomodulation
11%
Time to Pregnancy
11%
9 [(4 Acetyl 3 Hydroxy 2 Propylphenoxy)methyl] 3 (1h Tetrazol 5 Yl) 4h pyrido[1,2 A]pyrimidin 4 One
11%
Keyphrases
Anti-Mllerian Hormone
61%
Recurrent Pregnancy Loss
51%
Fertility Counseling
47%
Oocyte Donation
45%
Ovarian Reserve
45%
Denmark
42%
Antral Follicle Count
41%
Combined Oral Contraceptives
40%
Recurrent Miscarriage
40%
Fertility Assessment
36%
Ovarian Reserve Markers
36%
Live Birth Rate
34%
Young Women
32%
In Vitro Fertilization
27%
Intravenous Immunoglobulin (IVIg)
26%
Oocyte Cryopreservation
26%
Hormonal Contraception
24%
Oral Contraception
24%
Pregnancy Loss
23%
Secondary Recurrent Miscarriage
22%
Childhood Cancer
22%
Ovarian Hyperstimulation Syndrome
22%
Survivors
22%
Intracytoplasmic Sperm Injection
20%
Ovarian Function
20%
Fertility Preservation
19%
Preantral Follicles
18%
Live Birth
18%
Low Birth Weight
18%
Menstrual Cycle
17%
Donor Oocyte
16%
Chemotherapy
16%
Reproductive Lifespan
15%
Randomized Placebo-controlled Trial
15%
Ovarian Failure
14%
Miscarriage
14%
Placebo
14%
Autotransplantation
13%
Immunomodulation
13%
Single Center
13%
Ovarian Follicle
13%
Confidence Interval
13%
Infertility
13%
Assisted Reproductive Technology
12%
Age at Menopause
12%
Pregnancy Outcome
12%
Randomized Controlled Trial
12%
Ovulatory
12%
Premature Ovarian Insufficiency
11%
Fetus
11%